Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,186.00
(
2.73%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
94.84
(
-6.30%
)
Bitcoin
71,021.14
(
-1.34%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122859
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 54966

Sunday, 11/18/2007 8:20:38 PM

Sunday, November 18, 2007 8:20:38 PM

Post# of 257375
>My thought was could they buy teva ($10b sales) and use a model similar to novartis to put its own products generic but still control the channel somewhat.<

I think Dubi (a.k.a. midastouch) was the first one to make such a prediction on this board (#msg-8960225). At the time, I thought it was far-fetched, but it seems less far-fetched today.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today